Inhibikase Therapeutics (IKT) FCF Margin (2020 - 2023)
Inhibikase Therapeutics (IKT) posted FCF Margin of -344243100.00% for Q4 2023, down 344237505.23 percentage points from -5594.77% a year earlier and down 344237940.84 percentage points from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) FCF Margin (2020 - 2023) Analysis & Trends
For FY2023, Inhibikase Therapeutics' FCF Margin came in at -6947.87%, up 7305.49 percentage points from FY2022.
- Annual FCF Margin shows a three-year change of -6786.18 percentage points (FY2020 to FY2023).
- In prior years, Inhibikase Therapeutics' FCF Margin was -14253.37% in FY2022 (-13792.26 pp), -461.11% in FY2021 (-299.41 pp) and -161.69% in FY2020.
- The Q4 2023 figure stands as the lowest quarterly FCF Margin in data going back to Q1 2020.
- On a year-over-year basis, FCF Margin increased in three of the last eight quarters, with an average year-over-year change of -43006192.58 percentage points.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2022, with a gain of 205095.40 percentage points; the weakest was Q4 2023, with a drop of 344237505.23 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -5159.16% (Q3 2023), -3921.82% (Q2 2023) and -9256.10% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Inhibikase Therapeutics | 357.87 Mn | -227.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -344,243,100.00% |
| Sep 30, 2023 | -5,159.16% |
| Jun 30, 2023 | -3,921.82% |
| Mar 31, 2023 | -9,256.10% |
| Dec 31, 2022 | -5,594.77% |
| Sep 30, 2022 | -78,245.73% |
| Jun 30, 2022 | -66,480.49% |
| Mar 31, 2022 | -8,546.84% |
| Dec 31, 2021 | -210,690.17% |
| Sep 30, 2021 | -615.14% |
| Jun 30, 2021 | -311.55% |
| Mar 31, 2021 | -279.58% |
| Dec 31, 2020 | -555.42% |
| Sep 30, 2020 | 200.41% |
| Jun 30, 2020 | -1.33% |
| Mar 31, 2020 | -94.33% |
API Access
Inhibikase Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();